日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Trastuzumab-Deruxtecan for the Treatment of Metastatic Breast Cancer Patients: Data from Real World Studies

曲妥珠单抗-德鲁替康治疗转移性乳腺癌患者:来自真实世界研究的数据

Quaquarini, Erica; Luelli, Federica; Lasagna, Angioletta; Rizzo, Gianpiero; Perrone, Lorenzo; Figini, Simone; Achille, Raffaella; Pedrazzoli, Paolo

Adjuvant abemaciclib in early-stage breast cancer: hypothesis-generating safety observations from a real-world cohort study

早期乳腺癌辅助治疗中阿贝西利:来自真实世界队列研究的假设生成性安全性观察

Sottotetti, Federico; Figini, Simone; Gambini, Giulia; Rizzo, Gianpiero; Chessa, Giulia; Quaquarini, Erica; Palumbo, Raffaella; Perrone, Lorenzo; Tagliaferri, Barbara; Ferrari, Alessandra; Klersy, Catherine; Pedrazzoli, Paolo; Locati, Laura Deborah; Lasagna, Angioletta

BRCA2-Related Hereditary Cancer Syndrome-Associated Small Bowel Adenocarcinoma With Multiple BRCA2 Mutations: A Case Report and Review of the Literature

BRCA2相关遗传性癌症综合征伴多发BRCA2突变的小肠腺癌:病例报告及文献复习

Antoci, Francesca; Colella, Tommaso; Biletta, Elena; Travaglino, Erica; De Lisi, Giuseppe; Quaquarini, Erica; Arpa, Giovanni; Pisacane, Alberto Maria; Paris, Myriam Katja; Corallo, Salvatore; Di Sabatino, Antonio; Leone, Francesco; Vanoli, Alessandro

Prognostic and Predictive Roles of HER2 Status in Non-Breast and Non-Gastroesophageal Carcinomas

HER2状态在非乳腺癌和非胃食管癌中的预后和预测作用

Quaquarini, Erica; Grillo, Federica; Gervaso, Lorenzo; Arpa, Giovanni; Fazio, Nicola; Vanoli, Alessandro; Parente, Paola

Efficacy and activity of treatments after progression from palbociclib plus endocrine therapy in patients with HR(+)/HER2(-) metastatic breast cancer: a prospective, monocentric study

帕博西尼联合内分泌治疗后进展的HR(+)/HER2(-)转移性乳腺癌患者的治疗疗效和活性:一项前瞻性单中心研究

Palumbo, Raffaella; Quaquarini, Erica; Saltalamacchia, Giuseppe; Malovini, Alberto; Lapidari, Pietro; Tagliaferri, Barbara; Mollica, Ludovica; Teragni, Cristina Maria; Barletta, Chiara; Locati, Laura Deborah; Sottotetti, Federico

Health-related quality of life and clinical complexity of a real-life cohort of patients with advanced HR(+)/HER2(-) breast cancer treated with CDK4/6 inhibitors and endocrine therapy

接受 CDK4/6 抑制剂和内分泌治疗的晚期 HR(+)/HER2(-) 乳腺癌患者的真实世界队列的健康相关生活质量和临床复杂性

Tagliaferri, Barbara; Mollica, Ludovica; Palumbo, Raffella; Leli, Claudia; Malovini, Alberto; Terzaghi, Matteo; Quaquarini, Erica; Teragni, Cristina; Maccarone, Stefano; Premoli, Andrea; Sottotetti, Federico

Prognostic Role of Pathological Complete Response in Early Stage Epithelial Solid Tumors

病理完全缓解在早期上皮性实体瘤中的预后作用

Saltalamacchia, Giuseppe; Bernardo, Antonio; Quaquarini, Erica

Claudin-18 expression in small bowel adenocarcinoma: a clinico-pathologic study

小肠腺癌中 Claudin-18 的表达:一项临床病理学研究

Arpa, Giovanni; Fassan, Matteo; Guerini, Camilla; Quaquarini, Erica; Grillo, Federica; Angerilli, Valentina; Guzzardo, Vincenza; Lonardi, Sara; Bergamo, Francesca; Lenti, Marco Vincenzo; Pedrazzoli, Paolo; Paulli, Marco; Di Sabatino, Antonio; Vanoli, Alessandro

Clinical and Biological Variables Influencing Outcome in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Anti-PD-1/PD-L1 Antibodies: A Prospective Multicentre Study

影响接受抗PD-1/PD-L1抗体治疗的晚期非小细胞肺癌(NSCLC)患者预后的临床和生物学变量:一项前瞻性多中心研究

Quaquarini, Erica; Sottotetti, Federico; Agustoni, Francesco; Pozzi, Emma; Malovini, Alberto; Teragni, Cristina Maria; Palumbo, Raffaella; Saltalamacchia, Giuseppe; Tagliaferri, Barbara; Balletti, Emanuela; Rinaldi, Pietro; Canino, Costanza; Pedrazzoli, Paolo; Bernardo, Antonio

The prognostic role of variations in tumour markers (CEA, CA15.3) in patients with metastatic breast cancer treated with CDK4/6 inhibitors

肿瘤标志物(CEA、CA15.3)变化在接受 CDK4/6 抑制剂治疗的转移性乳腺癌患者中的预后作用

Sottotetti, Federico; Ferraris, Elisa; Tagliaferri, Barbara; Palumbo, Raffaella; Quaquarini, Erica; Teragni, Cristina; Balletti, Emanuela; Leli, Claudia; Premoli, Andrea; Mollica, Ludovica; Puglisi, Silvia; Sardi, Silvia; Malovini, Alberto; Pedrazzoli, Paolo; Bernardo, Antonio